2026 CBF 2.0——LC-ICP-MS法测定人血浆中亚砷酸（As-III）、砷酸 （As-V）、单甲基砷酸（MMA-V）和二甲基砷酸 （DMA-V）含量
2026.10.28
2026 CBF 2.0——大鼠乳汁中寡核苷酸样品前处理方法对比—— 固相萃取法和磁珠提取法
2026.10.28
2026 CBF 2.0——MSD法定量测定人血清中CD3/CD19双特 异性抗体（Blincyto类似药）浓度的方法
2026.10.28
2026 CBF 2.0——快速荧光灶抑制试验法 (RFFIT) 测定人血清中狂犬病毒中和抗体活性 的方法学验证
2026.10.28
2026 CBF 2.0——一种通过GC-MS/MS高效测定特殊小分子的生物分析方法
2026.10.28
2026 SOT - Summary of Three Toxicity Study of Repeated Intravenous Infusion of Exatecan Derivative-ADCs to Cynomolgus Monkey
2026.09.04
2026 SOT - Overcoming the DART Assessment Bottleneck in Transgenic Mice：Study design Strategies Informed by Historical Control Data
2026.09.04
2026 SOT - Optimizing Dosing Initiation in Rabbit Embryo-Fetal Development Toxicity Studies Avoiding the Pre-implantation Window
2026.09.04
2026 SOT - Immunogenicity and Toxicity of rAAV Gene Therapies in Non-human Primates in Preclinical Safety Evaluation
2026.09.04
2026 SOT - Consideration of Implementation for Postmarketing Carcinogenicity Studies Based on a Retrospective Analysis of Approved New Drugs by US FDA in the Past Ten Years
2026.09.04
